Skip To Main Content
Brendan Crowley on Muck Rack

Brendan Crowley

Verified
Middletown
As seen in: Bristol Press, Nature, Wiley Online Library, Yahoo Canada, Chron, Yahoo Sports Canada, Popular Mechanics, Yahoo, Yahoo Movies Canada, JD Supra, NewsBreak and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Brendan

Contact Brendan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

10 Key Takeaways: Where Energy Meets Data Center Development

|
By Brendan Crowley Verified, Sara Sayles
| JD Supra
At the 2026 World Services Group Americas Regional Meeting in Seattle, we unpacked the real dynamics shaping energy and data center co-development—from grid constraints and Battery Energy Storage System (BESS) permitting to global expansion and the rise of community engagement as a project-critical discipline. For roughly two decades, U.S. utilities enjoyed slow, predictable load growth.
Open in Who Shared Issue with article?

10 Key Takeaways: Where Energy Meets Data Center Development

|
By Brendan Crowley Verified, Sara Sayles
| schwabe.com
At the 2026 World Services Group Americas Regional Meeting in Seattle, we unpacked the real dynamics shaping energy and data center co-development—from grid constraints and Battery Energy Storage System (BESS) permitting to global expansion and the rise of community engagement as a project-critical discipline. For roughly two decades, U.S. utilities enjoyed slow, predictable load growth.
Open in Who Shared Issue with article?

Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosis - Nature Medicine Original

|
By Brendan Crowley Verified, Helena I. Boshoff, Christopher Boyce, Sangmi Oh, Firat Kaya, Véronique Dartois, Aidan Boving, Gregory T. Roberston
| Nature Verified
Abstract Linezolid, an oxazolidinone, is a cornerstone of treatment regimens for highly drug-resistant tuberculosis but cannot be used in drug-susceptible disease because of toxicity. This toxicity results from inhibition of mammalian mitochondrial protein synthesis. Here we show the development of a new oxazolidinone, MK-7762, with antitubercular activity that is better than linezolid and limited mitochondrial protein synthesis inhibition.
Open in Who Shared View Duplicates (2) Issue with article?
See all 1,664 licensed articles (1,734 Total)